Danaher Total Liabilities 2010-2022 | DHR

Danaher total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Danaher total liabilities for the quarter ending June 30, 2022 were $35.205B, a 0.16% decline year-over-year.
  • Danaher total liabilities for 2021 were $38.007B, a 4.46% increase from 2020.
  • Danaher total liabilities for 2020 were $36.384B, a 14.42% increase from 2019.
  • Danaher total liabilities for 2019 were $31.8B, a 62.2% increase from 2018.
Danaher Annual Total Liabilities
(Millions of US $)
2021 $38,007
2020 $36,384
2019 $31,800
2018 $19,606
2017 $20,281
2016 $22,219
2015 $24,458
2014 $13,542
2013 $12,221
2012 $13,857
2011 $12,978
2010 $8,444
2009 $7,965
Danaher Quarterly Total Liabilities
(Millions of US $)
2022-06-30 $35,205
2022-03-31 $37,030
2021-12-31 $38,007
2021-09-30 $39,037
2021-06-30 $35,261
2021-03-31 $34,996
2020-12-31 $36,384
2020-09-30 $34,918
2020-06-30 $34,996
2020-03-31 $37,864
2019-12-31 $31,800
2019-09-30 $28,336
2019-06-30 $21,109
2019-03-31 $20,206
2018-12-31 $19,606
2018-09-30 $20,034
2018-06-30 $20,831
2018-03-31 $19,943
2017-12-31 $20,281
2017-09-30 $20,471
2017-06-30 $21,052
2017-03-31 $21,454
2016-12-31 $22,219
2016-09-30 $18,033
2016-06-30 $26,383
2016-03-31 $23,809
2015-12-31 $24,458
2015-09-30 $26,524
2015-06-30 $12,815
2015-03-31 $12,682
2014-12-31 $13,542
2014-09-30 $11,726
2014-06-30 $11,863
2014-03-31 $12,014
2013-12-31 $12,221
2013-09-30 $12,350
2013-06-30 $12,744
2013-03-31 $12,720
2012-12-31 $13,857
2012-09-30 $12,633
2012-06-30 $12,803
2012-03-31 $12,530
2011-12-31 $12,978
2011-09-30 $14,056
2011-06-30 $14,958
2011-03-31 $8,311
2010-12-31 $8,444
2010-09-30 $8,326
2010-06-30 $8,021
2010-03-31 $8,027
2009-12-31 $7,965
2009-09-30 $7,951
2009-06-30 $7,720
2009-03-31 $7,670
Sector Industry Market Cap Revenue
Multi-Sector Conglomerates Diversified Operations $216.597B $29.453B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
General Electric (GE) United States $87.647B 31.84
3M (MMM) United States $86.717B 15.39
Carlisle (CSL) United States $16.164B 19.15
ITT (ITT) United States $6.877B 20.79
Federal Signal (FSS) United States $2.584B 24.35
Griffon (GFF) United States $1.912B 10.09
Vector Group (VGR) United States $1.664B 10.54
Lsb Industries (LXU) United States $1.209B 5.18
Steel Partners Holdings LP (SPLP) United States $0.960B 12.97
National Presto Industries (NPK) United States $0.540B 32.18
INNOVATE (VATE) United States $0.129B 0.00